Anti‐oncogenic PTEN induces ovarian cancer cell senescence by targeting P21
Open Access
- 13 October 2021
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 46 (1), 118-128
- https://doi.org/10.1002/cbin.11709
Abstract
Deletion and mutation of phosphatase and tensin homolog deleted on chromosome10 (PTEN) are closely associated with the occurrence of tumors. Tumor suppressor gene PTEN mutation plays an important role in the pathogenesis of ovarian cancer. However, it has been unclear whether it can regulate the senescence of ovarian cancer cells. We speculated that PTEN might inhibit the occurrence and development of ovarian cancer by promoting the expression of P21. We found that the expression of TRIM39 in human ovarian cancer was significantly diminished. In SKOV3 cells treated with naringin, the expression of TRIM39, which binds P21 and inhibits P21 degradation, was significantly elevated. Real-time PCR, western blot and immunofluorescence were used to detected the expression of PTEN, p21 and TRIM39, β-galactosidase Staining was used to detect cell senescence, Ki67 staining was used to observe cell proliferation, Trim39 interference or overexpression assay was used to detect its function. We speculated that PTEN might promote SKOV3 cell senescence by increasing TRIM39 expression and decreasing P21 degradation. Furthermore, by interfering with TRIM39 in SKOV3 cells, we found that the expression of P21 was downregulated, and the number of senescent SKOV3 cells decreased. With overexpression of TRIM39 in SKOV3 cells, the expression of P21 was upregulated, and the number of senescent SKOV3 cells increased. When naringin, a PTEN agonist, was added to SKOV3 cells in which TRIM39 protein was interfered with, the expression of P21 was significantly lower than that in the control group, and the number of senescent ovarian cancer cells was significantly diminished. Our results indicated that PTEN maintained the stability of P21 and decreased the degradation of P21 by increasing TRIM39 expression, thus promoting the senescence of SKOV3 cells, and PTEN maintained the stability of p21 and promoted the aging of SKOV3 cells might be a novel therapeutic target for Ovarian Cancer.Keywords
This publication has 30 references indexed in Scilit:
- TRIM39 regulates cell cycle progression and DNA damage responses via stabilizing p21Proceedings of the National Academy of Sciences of the United States of America, 2012
- Ubiquitylation of p53 by the APC/C inhibitor Trim39Proceedings of the National Academy of Sciences of the United States of America, 2012
- The Trim39 ubiquitin ligase inhibits APC/CCdh1-mediated degradation of the Bax activator MOAP-1The Journal of cell biology, 2012
- The functions and regulation of the PTEN tumour suppressorNature Reviews Molecular Cell Biology, 2012
- Selective Ubiquitylation of p21 and Cdt1 by UBCH8 and UBE2G Ubiquitin-Conjugating Enzymes via the CRL4Cdt2 Ubiquitin Ligase ComplexMolecular and Cellular Biology, 2011
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigmHuman Pathology, 2011
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryThe American Journal of Surgical Pathology, 2010
- p21 in cancer: intricate networks and multiple activitiesNature Reviews Cancer, 2009
- TRIM39 is a MOAP-1-binding protein that stabilizes MOAP-1 through inhibition of its poly-ubiquitination processExperimental Cell Research, 2009
- Moya-Moya Syndrome and Primary Pulmonary Hypertension in ChildhoodNeuropediatrics, 1990